Pharmaceuticals (Jul 2023)

The Glutaminase-1 Inhibitor [<sup>11</sup>C-carbony]BPTES: Synthesis and Positron Emission Tomography Study in Mice

  • Yiding Zhang,
  • Katsushi Kumata,
  • Lin Xie,
  • Yusuke Kurihara,
  • Masanao Ogawa,
  • Tomomi Kokufuta,
  • Nobuki Nengaki,
  • Ming-Rong Zhang

DOI
https://doi.org/10.3390/ph16070963
Journal volume & issue
Vol. 16, no. 7
p. 963

Abstract

Read online

Bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide (BPTES) is a selective inhibitor of glutaminase-1 (GLS1), consequently inhibiting glutaminolysis. BPTES is known for its potent antitumor activity and plays a significant role in senescent cell removal. In this study, we synthesized [11C-carbonyl]BPTES ([11C]BPTES) as a positron emission tomography (PET) probe for the first time and assessed its biodistribution in mice using PET. [11C]BPTES was synthesized by the reaction of an amine precursor () with [11C-carbonyl]phenylacetyl acid anhydride ([11C]2), which was prepared from [11C]CO2 and benzyl magnesium chloride, followed by in situ treatment with isobutyl chloroformate. The decay-corrected isolated radiochemical yield of [11C]BPTES was 9.5% (based on [11C]CO2) during a synthesis time of 40 min. A PET study with [11C]BPTES showed high uptake levels of radioactivity in the liver, kidney, and small intestine of mice.

Keywords